Business COVID 19

Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn

Norway said Covid-19 vaccines may be too risky for the very old and terminally ill, the most cautious statement yet from a European health authority as countries assess the real-world side effects of the first shots to gain approval. Norwegian officials said 23 people had died in the country a short time after receiving their […]

Business COVID 19

Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines

Global drugmakers added to doubts raised about Britain’s strategy for giving Covid-19 vaccines to as many people as possible in the shortest amount of time. Industry groups representing pharmaceutical companies in the U.S. and Europe on Wednesday joined the top medicines regulators in both markets in questioning any moves to alter the timing or dosage […]

Business

EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations

Moderna Inc.’s COVID-19 vaccine won the backing of the European Union drugs regulator, clearing the way for a second weapon in the bloc’s fight to stem the pandemic. The recommendation was announced by the European Medicines Agency on Wednesday. The European Commission is working “at full speed” on the final clearance step, President Ursula Von […]

COVID 19 Tech

Experts debate fiddling with vaccine doses as virus rages out of control

Enlarge / Vials of undiluted Pfizer COVID-19 vaccine are prepared to administer to staff and residents at the Goodwin House Bailey’s Crossroads, a senior living community in Falls Church, Virginia, on December 30, 2020. (credit: Getty | BRENDAN SMIALOWSKI ) With the pandemic continuing to surge to new heights, debate has erupted among experts about […]

Business COVID 19

U.K. approves AstraZeneca COVID-19 vaccine

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today. The U.K. government has approved AstraZeneca’s COVID-19 vaccine for emergency use, becoming the first government to do so. The decision by the U.K. drugs regulator will clear the way for tens of millions of Britons […]

Business COVID 19

AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week

The U.K. is poised to approve the COVID-19 vaccine produced by AstraZeneca Plc and the University of Oxford, giving the country another powerful tool to fight the pandemic as concern mounts over rising infections. Britain’s drug regulator could clear the shot for use as early as this week, according to a person familiar with the […]

Business COVID 19

Why Wall Street is’Indicating caution’ to your Own Stock portfolio at 2021 

Here is the internet edition of Bull Sheet, a yearlong day-to-day newsletter about what is happening in the market. Subscribe to receive it sent directly to your inbox. Excellent morning. Stocks and Stocks have been rebounding on Tuesday. This ’s little to no advancement on stimulation negotiations in Washington, or about Brexit trade discussions in Europe. Elsewhere, […]

Business COVID 19

Why Investors had a Serious Negative reaction to AstraZeneca’s Alexion Bargain

Our assignment to generate business better would be fueled by viewers just like you. AstraZeneca’s buy of Alexion at a 39 billion cash-and-stock bargain hasn’t impressed AZ’s investors. They shipped the organization’s shares tumbling aggressively in Monday trading. At one point, AZ’s stocks on the London Stock Exchange were down over 7 percent, before rebounding […]

Business COVID 19

COVID Vaccines are Arriving –but it May Be too late to the Home market

Here is the internet edition of Bull Sheet, a yearlong day-to-day newsletter about what is happening in the markets. Subscribe to receive it sent directly to your inbox. It’s shaping up for a risk-off Monday as traders emphasise that the impending birth of deadly doses. The imports couldn’t come in a greater –or, depending upon your view, […]

Business

AstraZeneca acquires rare-disease Pro Alexion at $39 billion Bargain

AstraZeneca Plc, among the drugmakers directing the struggle against Covid-19, highlighted in which its expansion will come out following the pandemic having a 39 billion agreement to get rare-disease expert Alexion Pharmaceuticals Inc.. The suggested cash-and-stock acquisition will include remedies for rare blood and gynecological ailments to the portfolio of Cambridge, U.K.-based AstraZeneca, that had […]